Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reports the completion of a Phase 1/2 safety and efficacy study of CTX131 in adults with relapsed or refractory solid tumors, including cl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Clear Cell Renal Cell Carcinoma
• Esophageal Cancer
• Malignant Pleural Mesothelioma
• Pancreatic Adenocarcinoma

Drugs mentioned

• CTX131

Snippet

Sponsor: CRISPR Therapeutics AG | Conditions: Clear Cell Renal Cell Carcinoma, Cervical Carcinoma | Phase 1, Phase 2 | Status: COMPLETED